NCT06357754Recrutement en cours
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Résumé
The purpose of this transgene assay testing service is to evaluate tumor samples for transgene levels in patients who received a commercially available Bristol-Myers Squibb manufactured gene modified cellular therapy and have reported a qualifying second malignancy.
Critères d'inclusion
• Participant has received a commercially available Bristol-Myers Squibb (BMS) manufactured Gene Modified Cell Therapy (GMCT) and has been diagnosed with a qualifying second primary malignancy or a second primary malignancy which BMS has qualified for testing. • Participant has received a commercially available BMS manufactured GMCT in a clinical trial or other investigational setting (including non-conforming product) for which there is no testing protocol in place for that trial or investigational setting and has been diagnosed with a qualifying second primary malignancy or a second primary malignancy which BMS has qualified for testing.
Critères d'exclusion
• Participant is actively participating in a clinical trial where information and sample collection is being conducted under that clinical trial. • Participant has not received a BMS manufactured GMCT or has not been diagnosed with a qualifying second primary malignancy.
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- —
- Type d'étude
- Observationnelle
- Pays
- Suisse, Allemagne, États-Unis, Japon
- Promoteur
- Bristol-Myers Squibb(Industrie)
- N° de protocole
- CA082-085
- Pathologies
- Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia, Multiple Myeloma
- Interventions
- Biologique
Traitements évalués
- Idecabtagene vicleucel
- Lisocabtagene maraleucel
Lieux · 5
- Aarau, SuisseKantonsspital AarauRecrute dans ce centre
- Essen, AllemagneUniversitaetsklinikum Essen (AoR)Recrute dans ce centre
- Dallas, États-UnisUt SouthwesternRecrute dans ce centre
- Salt Lake City, États-UnisHuntsman Cancer Institute at the University of UtahRecrute dans ce centre
- Toyokawa, JaponToyokawa City HospitalRecrute dans ce centre
Au total, dans le monde, 5 des 8 centres listés au registre recrutent ; les 3 autres ne recrutent pas actuellement.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 22 janvier 2026).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.